Time-resolved laser-induced fluorescence spectroscopy systems and uses thereof

Patent metadata

Field	Value
Publication number	US-10983060-B2
Application number	US-201916382791-A
Country	US
Kind code	B2
Filing date	Apr 12, 2019
Priority date	Mar 15, 2013
Publication date	Apr 20, 2021
Grant date	Apr 20, 2021

Abstract

The invention provides systems for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation and methods for using the same. The system includes a laser source, collection fibers, a demultiplexer and an optical delay device. All references cited herein are incorporated by reference in their entirety as though fully set forth. Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

First claim

The invention claimed is:

1. A system for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation comprising:
(a) a laser source connected to a biological sample via excitation fibers (ExF), wherein the laser source is configured to irradiate the biological sample with a laser pulse at a predetermined wavelength to cause the biological sample to produce a responsive fluorescence signal;
(b) collection fibers (CF), wherein the CF collect the responsive fluorescence signal from the biological sample, and relays the fluorescence signal to a plurality of filters; and
(c) the plurality of filters, each filter of the plurality of filters being configured to split the responsive fluorescence signal at pre-determined wavelengths to obtain spectral bands,
wherein a first spectral band comprises wavelengths within a range of 365-410 nm, a second spectral band comprises wavelengths within a range of 410-450 nm, a third spectral band comprises wavelengths within a range of 450-480 nm, a fourth spectral band comprises wavelengths within a range of 500-560 nm, and a fifth spectral band comprises wavelengths greater than 600 nm.

2. The system of claim 1 , wherein a sixth spectral band comprises wavelengths of less than 365 nm.

3. The system of claim 1 , further comprising an optical delay device.

4. The system of claim 3 , wherein the optical delay device is adapted to couple the spectral bands from the plurality of filters into the optical delay device, allow the spectral bands to travel through the optical delay device, and introduce a controlled time delay to the spectral bands as the spectral bands travel through the optical delay device.

5. The system of claim 3 , wherein the optical delay device comprises a plurality of optical fibers.

6. The system of claim 5 , wherein two or more of the plurality of optical fibers have different optical path lengths.

7. The system of claim 1 , wherein the plurality of filters comprises at least three filters.

8. The system of claim 1 , wherein the plurality of filters form a demultiplexer.

9. The system of claim 1 , wherein the CF form a single bundle.

10. The system of claim 1 , further comprising a photomultiplier tube configured to detect the spectral bands received from the plurality of filters.

11. The system of claim 10 , further comprising a digitizer configured to digitize the spectral bands received from the photomultiplier tube.

12. The system of claim 11 , further comprising a preamplifier configured to amplify the spectral bands received from the photomultiplier tube before the spectral bands are digitized by the digitizer.

13. The system of claim 11 , further comprising a computer system configured to process and display the spectral bands received from the digitizer.

14. A method for characterizing a biological sample by analyzing emission of fluorescent light from the biological sample upon excitation comprising:
(a) irradiating the biological sample with a laser pulse at a predetermined wavelength to cause the biological sample to produce a responsive fluorescence signal;
(b) collecting the responsive fluorescence signal from the biological sample; and
(c) splitting the responsive fluorescence signal with a plurality of filters, each filter of the plurality of filters being configured to split the responsive fluorescence signal at pre-determined wavelengths to obtain spectral bands,
wherein a first spectral band comprises wavelengths within a range of 365-410 nm, a second spectral band comprises wavelengths within a range of 410-450 nm, a third spectral band comprises wavelengths within a range of 450-480 nm, a fourth spectral band comprises wavelengths within a range of 500-560 nm, and a fifth spectral band comprises wavelengths greater than 600 nm.

15. The method of claim 14 , wherein a sixth spectral band comprises wavelengths of less than 365 nm.

16. The method of claim 14 , wherein the responsive fluorescence signal is emitted by a biomolecule.

17. The method of claim 16 , wherein the biomolecule is any one or more of PLP-GAD (pyridoxal-5′-phosphate (PLP) glutamic acid decarboxylase (GAD)), bound NADH, free NADH, flavin mononucleotide (FMN) riboflavin, lipopigments, endogenous porphyrins, or a combination thereof.

18. A method for determining tissue viability comprising analyzing emission of fluorescence signals from biomolecules in the tissue by the method of claim 14 , wherein an increase in fluorescence of the biomolecules in the biological sample relative to a normal sample is indicative of poor tissue viability.

19. A method for continuously monitoring cellular metabolism comprising analyzing emission of a fluorescence signal by the method of claim 14 .

20. A method for determining drug or metabolite level in plasma comprising analyzing emission of a fluorescence signal from a biomolecule by the method of claim 14 .

21. The method of claim 14 , further comprising (d) passing the spectral bands through a time-delay mechanism; (e) obtaining the time-delayed spectral bands; and (f) processing the time-delayed spectral bands.

22. The method of claim 21 , wherein processing the time-delayed spectral bands comprises detecting the time-delayed spectral bands.

23. The method of claim 22 , further comprising digitizing the detected signal.

24. The method of claim 23 , further comprising amplifying the detected signal before digitizing the detected signal.

25. The method of claim 23 , further comprising processing and displaying the digitized signal with a computer system.

Assignees

• Cedars Sinai Medical Center

Inventors

• Butte Pramod
• Lapchak Paul
• Kittle David Scott

Classifications

• A61B5/1459

  invasive, e.g. introduced into the body by a catheter · CPC title

• A61B5/0071

  by measuring fluorescence emission · CPC title

• G01N21/6402

  Atomic fluorescence; Laser induced fluorescence · CPC title

• G01N2021/6421

  Measuring at two or more wavelengths · CPC title

• A61B5/14556

  by fluorescence (A61B5/14555 takes precedence) · CPC title